bullish

Akeso (康方生物) Placement - Prepping for Commercialization

316 Views06 Jan 2021 18:28
Akeso Biopharma Inc (9926 HK) is looking to raise about US$154m from its primary placement to fund its expansion plans which includes building comm team, new production facility, and etc.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Zhen Zhou, Toh
APAC IPOs & Placements
x